Alcohol withdrawal syndrome, or the sudden cessation of heavy drinking among people with alcohol use disorder, is associated with higher risks of surgical complications, according to surgeons at the ...

Alcohol withdrawal syndrome (AWS) is a potentially life-threatening condition that may complicate patients' recovery after surgery. About 28.9 million people age 12 and older in the United States have ...

CHICAGO — Patients who develop alcohol withdrawal syndrome (AWS) after major surgery face significantly higher risks of complications, longer hospital stays, and increased health care costs, according ...

Emergency departments may be missing opportunities to identify and treat people for problem alcohol use. A new study published in Alcohol, Clinical and Experimental Research found that less than 1% of ...

PULLMAN, Wash. – Researchers at Washington State University are exploring a new approach to treating alcohol withdrawal syndrome, focusing on the cerebellum, a part of the brain often overlooked in ...

Risks include respiratory failure, sepsis, and significantly higher health care utilization and costs. (HealthDay News) — Patients undergoing major surgery who experience alcohol withdrawal syndrome ...

About The Study: In this cohort study of a large primary care population served by an integrated health system, alcohol withdrawal syndrome (AWS) hospitalizations were common, especially in male ...

A quantitative alcohol history should be recorded for all patients, because alcohol use contributes to many physical and mental disorders. A person-centered, nonjudgmental approach should be adopted.

Add Yahoo as a preferred source to see more of our stories on Google. New research suggests the cerebellum helps drive alcohol withdrawal distress. A targeted compound eased symptoms in mice without ...

Stopping alcohol consumption triggers immediate physical and mental changes. The timeline and intensity vary depending on drinking patterns, overall health, and individual factors. When a person stops ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has announced it will review the use of medicines containing sodium oxybate, a drug used in narcolepsy, ...